Skip to search formSkip to main contentSkip to account menu

moexipril

Known as: 2-((1-ethoxycarbony)-3-phenylpropylamino-1-oxopropyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, Moexiprilum, moexipril [Chemical/Ingredient] 
A non-sulfhydryl angiotensin converting enzyme (ACE) inhibitor with antihypertensive activity. As a prodrug, moexipril is hydrolyzed into its active… 
National Institutes of Health

Related topics

Related topics

18 relations
AngioedemaAngiotensin-Converting Enzyme Inhibitors [MoA]Congestive heart failureDecreased Blood Pressure [PE]

Broader (3)

Angiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsTetrahydroisoquinolines

Narrower (4)

FempressMoexipril hydrochlorideRS 10085Univasc

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
In vitro modeling of angiotensin-converting enzyme inhibitor's absorption with chromatographic retention data and selected molecular descriptors.
2006
2006
Monitoring the metabolism of moexipril to moexiprilat using high-performance liquid chromatography-electrospray ionization mass spectrometry.
High-performance liquid chromatography combined with a UV absorbance detector and electrospray ionization mass spectrometer is… 
2003
2003
ACE Inhibition with Moexipril
ACE inhibitors induce metabolic changes and exert cardioprotective and vasoprotective properties, some of which cannot be… 
Review
1998
Review
1998
Multiple sclerosis: what have we learned from magnetic resonance imaging studies?
We review studies that have examined the relationship between magnetic resonance imaging findings and clinical disability… 
1997
1997
USEFULNESS OF MOEXIPRIL AND HYDROCHLOROTHIAZIDE IN MODERATELY SEVERE ESSENTIAL HYPERTENSION
The purpose of this study was to assess the efficacy and tolerability of the angiotensin-converting enzyme inhibitor moexipril… 
1996
1996
Moexipril versus captopril in patients with mild to moderate hypertension.
Moexipril is a new, long-acting angiotensin-converting enzyme (ACE) inhibitor. In contrast to captopril, it is a prodrug of the… 
1995
1995
THE ANTIHYPERTENSIVE PROPERTIES OF THE ANGIOTENSIN‐CONVERTING ENZYME INHIBITOR MOEXIPRIL GIVEN ALONE OR IN COMBINATION WITH A LOW DOSE OF A DIURETIC
The antihypertensive characteristics of the angiotensin-converting enzyme inhibitor moexipril were evaluated in 413 patients with… 
1995
1995
Tricenter Assessment of the Efficacy of the ACE Inhibitor, Moexipril, by Ambulatory Blood Pressure Monitoring
To assess the efficacy and time‐dependent effects of once‐daily moexipril, a nonsulfhydryl ester prodrug of the angiotensin… 
1994
1994
Comparison of the efficacy of three dose levels of moexipril versus placebo as add-on therapy to hydrochlorothiazide in patients with moderate hypertension.
This parallel, double-blind trial was designed to evaluate the efficacy of three dose levels of moexipril versus placebo as add… 
1989
1989
An Unexpected pH Effect on the Stability of Moexipril Lyophilized Powder
Because of the limited stability of moexipril (RS-10085; 1) in aqueous solution, lyophilized parenteral formulations were… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)